CAR-T Meeting 2023 | CAR-T therapy in myeloma: moving into earlier lines and treating patients with unmet medical needs
Paula Rodríguez-Otero
• 16 Feb 2023
Paula Rodríguez-Otero, MD, PhD, University Clinic of Navarra, Pamplona, Spain, discusses the possibility of moving CAR-T therapy into earlier lines in multiple myeloma, emphasizing the clinical efficacy of these agents. Dr Rodríguez-Otero also comments on how CAR-T cells may play an important role in the treatment of patients with unmet medical needs, including those who relapse early after frontline therapy and those who are refractory to lenalidomide. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
